Post a comment
Recent developments in Sierra Leone have brought to light a concerning issue regarding the distribution of expired Amlodipine tablets, with Harry’s SL Ltd at the center of the investigation. Health practitioners in the country have reported the presence of expired Amlodipine tablets, which have resulted in serious health complications for unsuspecting patients.
The Pharmacy Board of Sierra Leone issued a cautionary advisory on June 12, 2024, urging medical professionals to refrain from prescribing or using products manufactured by Nordic Pharmaceuticals company in India, citing ongoing concerns over product quality. Despite these warnings, the circulation of fake and expired drugs, including Amlodipine, persists.
During investigations, attempts to ascertain the importer of Nordic Pharmaceutical Products in Sierra Leone were met with obstacles. The Pharmacy Board declined to disclose this information and referred inquiries back to their official release. However, there are allegations implicating Harry’s SL Ltd as the sole importer of these products into Sierra Leone.
Efforts to obtain a response from the management of Harry’s SL Ltd regarding these allegations have been unsuccessful, suggesting a reluctance to engage with the media on this critical issue.
As the investigation continues, health authorities emphasize the importance of reviewing current treatment plans and considering alternative medications for affected patients
